2-(4-CHLOROPHENYL)-2-(4-METHYLPIPERAZIN-1-YL)ACETONITRILE, 95.0%, 1g

(2s)-2-Benzenesulfonamidopropanoic acid, 95%, 250mg

N-benzyltetrahydro-3-thiophenamine 1,1-dioxide hydrochloride, 95.0%, 10g

6-CHLORO-9-(2-FLUOROBENZYL)-9H-PURINE, 95.0%, 100mg

3-Amino-4-fluorobenzonitrile, 95.0%, 1g

2-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOINDOLIN-1-ONE, 95.0%, 1g

4-Amino-2-methoxypyridine, 97.0%, 10g

N-(3-(2,4-Dichlorophenoxy)propyl)-N-methylprop-2-yn-1-amine hydrochloride, 95.0%, 5mg

(S)-Methyl morpholine-3-carboxylate, 95.0%, 25g

3-METHYLISOTHIAZOL-4-AMINE HCL, 95.0%, 100mg

(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione, 97%, 100mg

Holder for preparations of 76 x 26 mm and culture dish with diameter 54 mm

2-(1H-imidazol-4-yl)phenol, 95%, 1g